Eric Winer holds a number of roles at the Dana-Farber Cancer Institute in Boston, Mass. He is chief clinical strategy officer, chief of the division of women’s cancers, senior vice president for medical affairs, and chief of the division of breast oncology for the Susan F. Smith Center for Women’s Cancers. He also holds the Thompson Chair in Breast Cancer Research and is a professor of medicine at Harvard Medical School.
Dr. Winer received his M.D. from Yale University in 1983 and later completed training in internal medicine and served as chief resident at Yale-New Haven Hospital. He subsequently was a fellow in hematology-oncology at Duke University Medical Center and from 1989 to 1997 served on the Duke faculty, where he became codirector of the multidisciplinary breast program.
Dr. Winer has conducted a wide range of clinical trials focusing on breast cancer and has additional research interests related to psychosocial aspects of oncology and health services research.
Can we help guide you?
Create a profile for better recommendations
Breast self-exam, or regularly examining your breasts on your own, can be an important way to...
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....
Breast Cancer Stages
The stage of a breast cancer is determined by the cancer’s characteristics, such as how large it...